Nilotinib, for Patients With CML-CP or CML-AP
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
Study of Efficacy and Safety of Voretigene Neparvovec in Japanese Patients With Biallelic RPE65 Mutation-associated Retinal Dystrophy
- Status
- COMPLETED
- Phase
- PHASE3
Study of Mechanism of Action of Ligelizumab (QGE031) in Patients With Chronic Urticaria
- Status
- TERMINATED
- Phase
- PHASE1
Managed Access Program Cohort Treatment Plan CTMT212X2002I to Provide Access to Trametinib and Dabrafenib Combination Therapy for Patients With BRAF V600 Mutation-positive Advanced Non-Small Cell Lung Cancer
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
MAP to Provide Access to Nilotinib, for Patients With HES
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Effective Study of ARNI on Ventricular Arrhythmia in HFrEF Patients With ICD or CRT-D (RHYTHM)
- Status
- TERMINATED
- Phase
- PHASE4
Compassionate Use Program to Access Trametinib and Dabrafenib for Patients With BRAF Mutation-positive Metastatic Melanoma
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
An Efficacy Study of Secukinumab in Plaque Psoriasis Patients With Subclinical Psoriatic Arthritis as Measured by Musculoskeletal Ultrasound
- Status
- WITHDRAWN
- Phase
- PHASE4
A Single Arm Study Evaluating the Efficacy, Safety and Tolerability of Ofatumumab in Patients With Relapsing Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE3
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
- Status
- RECRUITING
- Phase
- PHASE1
Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple Sclerosis
- Status
- RECRUITING
- Phase
- PHASE4
Canakinumab MAP in COVID-19 Pneumonia With CRS
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Managed Access Program to Provide Access to Alpelisib for Patients With Advanced Breast Cancer
- Status
- AVAILABLE
- Phase
- N/A
A Phase II, Open-Label, Multicenter Study of Capmatinib in Subjects With MET Exon 14 Skipping Mutation Positive, Advanced, NSCLC With Brain Metastases
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of Tisagenlecleucel in Chinese Adult Patients With Relapsed or Refractory Diffuse Large B-cell Non-Hodgkin Lymphoma (DLBCL)
- Status
- WITHDRAWN
- Phase
- PHASE2
The Effect of Anti-calcitonin Gene-related Peptide (CGRP) Receptor Antibodies on the Headache Inducing Properties of CGRP and Cilostazol in Migraine Patients
- Status
- UNKNOWN
- Phase
- NA
A Study of Dabrafenib in Combination With Trametinib in Chinese Patients With BRAF V600E Mutant Metastatic NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Study of Safety and Efficacy of Genome-edited Hematopoietic Stem and Progenitor Cells in Sickle Cell Disease (SCD)
- Status
- TERMINATED
- Phase
- PHASE1
EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005
- Status
- TERMINATED
- Phase
- PHASE2
Study of Capmatinib Efficacy in Comparison With Docetaxel in Previously Treated Participants With Non-small Cell Lung Cancer Harboring MET Exon 14 Skipping Mutation
- Status
- TERMINATED
- Phase
- PHASE3